These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11524749)

  • 1. [When the liver causes trouble].
    Jalanko H; Höckerstedt K
    Duodecim; 1998; 114(7):653-60. PubMed ID: 11524749
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation abnormalities in patients who have liver disease.
    Trotter JF
    Clin Liver Dis; 2006 Aug; 10(3):665-78, x-xi. PubMed ID: 17162234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gray-scale ultrasonography in the diagnosis of cholestasis].
    de Dios Vega JF; Calero Ayala B; Gálvez Calderón C; Gómez Camacho F; Bonilla Rosal F; Guerrero Jiménez P
    Rev Esp Enferm Apar Dig; 1981 Apr; 59(4):469-76. PubMed ID: 7268151
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
    Strople J; Lovell G; Heubi J
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between the thrombotest and prothrombin time in normal and pathological states].
    Plesch S; Vallimitjana V; Mercier A; Cosentino JJ
    Medicina (B Aires); 1966; 26(4):189-97. PubMed ID: 5981791
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analytical study of Quick test in hepatic insufficiency by differential determination of prothrombin, proconvertin and proaccelerin].
    ALAGILLE D; HARTMANN L; FAUVERT R
    Sem Hop; 1953 Oct; 29(66):3375-86. PubMed ID: 13113301
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical application of prothrombin time and coagulation factors in liver diseases].
    Li Q; Jia JD; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):767-8. PubMed ID: 15619355
    [No Abstract]   [Full Text] [Related]  

  • 8. Relevance of clotting tests in liver disease.
    Thachil J
    Postgrad Med J; 2008 Apr; 84(990):177-81. PubMed ID: 18424573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complicated polycystic liver disease with intracystic hemorrhage and obstructive jaundice].
    Rosenfeld L; Abergel A; Bonny C; Poincloux L; Gayard P; Garcier JM; Scribe-Outtas M; Bommelaer G
    Gastroenterol Clin Biol; 2001; 25(8-9):818-22. PubMed ID: 11598544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombin time in liver diseases].
    ALAGILLE D; SOULIER JP
    Rev Int Hepatol; 1957; 7(1):1-13. PubMed ID: 13432375
    [No Abstract]   [Full Text] [Related]  

  • 11. [BLOOD COAGULATION FROM THE STANDPOINT OF LIVER FUNCTION].
    UMEGAKI K
    Rinsho Byori; 1963 Sep; 11():492-9. PubMed ID: 14092898
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary sulfated bile acids: a new simple urine test for cholestasis in infants and children.
    Obatake M; Muraji T; Satoh S; Nishijima E; Tsugawa C
    J Pediatr Surg; 2002 Dec; 37(12):1707-8. PubMed ID: 12483636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology and therapy of pruritus in cholestatic liver diseases].
    Schachschal G; Schmidt H
    Z Gastroenterol; 2003 Jun; 41(6):627. PubMed ID: 12806549
    [No Abstract]   [Full Text] [Related]  

  • 14. An improved method for the assay of serum guanine deaminase activity.
    Quast NM; Clayson KJ; Strandjord PE
    Am J Med Technol; 1968 Sep; 34(9):513-21. PubMed ID: 5681411
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thromboelastography applied to the study of coagulation in liver diseases].
    SOARES AD; PARREIRA F
    J Med (Oporto); 1958 Mar; 35(791):705-6 passim. PubMed ID: 13525076
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation.
    Li M; Zhang LP; Yang L
    Chin Med J (Engl); 2007 Nov; 120(22):1963-8. PubMed ID: 18067779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation disorders in liver disease.
    Amitrano L; Guardascione MA; Brancaccio V; Balzano A
    Semin Liver Dis; 2002 Feb; 22(1):83-96. PubMed ID: 11928081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid system blockade decreases collagenase activity and improves liver injury in a rat model of cholestasis.
    Kiani S; Ebrahimkhani MR; Shariftabrizi A; Doratotaj B; Payabvash S; Riazi K; Dehghani M; Honar H; Karoon A; Amanlou M; Tavangar SM; Dehpour AR
    J Gastroenterol Hepatol; 2007 Mar; 22(3):406-13. PubMed ID: 17295775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of coagulation physiological studies in acute and chronic liver disease].
    BROICHER H; EGLI H; KESSELER K; OBERHOFFER G
    Dtsch Arch Klin Med; 1958; 205(3):292-309. PubMed ID: 13597688
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver disease, coagulation testing, and hemostasis.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):265-82. PubMed ID: 19665678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.